Myriad Genetics
MYGN
#7319
Rank
S$0.67 B
Marketcap
S$7.04
Share price
-1.44%
Change (1 day)
-26.92%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2026 (TTM): S-$1.75

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is S-$1.75. In 2025 the company made an earnings per share (EPS) of S-$5.08 a decrease over its 2024 EPS that were of S-$1.82.

EPS history for Myriad Genetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.75-65.6%
2025S-$5.08179.43%
2024S-$1.82-55.94%
2023S-$4.13130.22%
2022S-$1.79275.68%
2021S-$0.48-87.99%
2020S-$3.97755.56%
2019S-$0.46-194.74%
2018S$0.49-79.89%
2017S$2.44112.36%
2016S$1.15-35.97%
2015S$1.79-7.33%
2014S$1.93-37.24%
2013S$3.0859.33%
2012S$1.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
S$3.49-298.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
S-$6.86 291.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S-$0.12-93.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
S-$65.66 3,642.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
S$49.23-2,905.88%๐Ÿ‡บ๐Ÿ‡ธ USA